About Us

Founded in 2012, Kinsa’s mission is to stop the spread of infectious illness through early detection and early response.  As an Illness Insights Solutions company, Kinsa has built a comprehensive set of early warning and insights capabilities designed to provide individuals, schools, communities, businesses and public health officials with real-time knowledge of spreading illness. Aggregating illness data from traditional and state-of-the-art sources such as smart thermometers, Kinsa empowers these stakeholders to:

  • Guide individuals and families to treatment and prevention early, before they enter the healthcare system
  • Reduce transmission in schools and communities
  • Improve supply chain management, forecast product demand and target messaging to areas of rising illness
  • Detect novel outbreaks early, monitor intervention efficacy and accurately forecast seasonal flu at the local level

Our Leadership

Inder Singh, Founder and CEO

Inder founded Kinsa in 2012 with a mission to curb the spread of infectious illness through the use of technology.  Prior to Kinsa, he served as Executive Vice President of the Clinton Health Access Initiative (CHAI), where he brokered a series of agreements between 70 developing countries and 20 pharmaceutical companies to lower the price of AIDS, malaria and TB medicines. This work resulted in more than $1 billion in cost savings and enabled millions of children to access treatment.  Inder started his career as a software engineer and consultant. He holds three Masters degrees from Harvard University and MIT, and is a proud University of Michigan alum. 


Erin Koehler, Chief Product Officer

Erin joined Kinsa in 2013, and has spent the past 15 years leading product and analytics teams. Erin received her MBA from Berkeley in Social Entrepreneurship, Product & Business Model Design; and her BA from Tufts University in Quantitative Economics and International Relations.  Some of her previous accomplishments include launching novel health products in 10 countries while working at the Clinton Health Access Initiative. While at CHAI, Erin led the introduction of new, improved health products throughout Eastern and Southern Africa, and advised nine governments throughout Africa on initiatives to improve access to high-quality, low-cost medications to treat HIV and malaria.


Peter Van Riper, Chief Financial Officer

Peter started his career in public service, including a role as a writer for President Clinton.  Following a Wharton MBA and 3 years at Boston Consulting Group, Peter has pursued a series of entrepreneurial ventures in health care, participating in several exits, including the sale of his company Peak Dental Services in 2020.


Andy Yost, Chief Marketing Officer

Andy Yost joined Kinsa in 2021 as the first Chief Marketing Officer with responsibility for all marketing and communications. Most recently, he was the Chief Marketing Officer for Gannett (USA TODAY NETWORK) with responsibility for driving consumer revenue and brand engagement through the use of data, analytics and cutting-edge digital and brand marketing strategies across Gannett’s portfolio of national and local media brands.  Prior to Gannett, he held marketing leadership roles at Viacom, Dow Jones, Columbia House and American Express.  Andy received his MBA from Columbia Business School and graduated from Bucknell University with a Bachelor Science in Business Administration.

John Zicker, Vice President, Data Science

John’s work on advanced data science spans 4 decades and has seen him applying his expertise to fields as diverse as cybersecurity, life sciences drug discovery, particle beam experiments, and business intelligence. John is a 5-time entrepreneur and 3-time CEO.  John holds a BS in Electrical Engineering from the University of California at Davis as well as a Master’s of Engineering from the University of Wisconsin-Madison.  Some highlights of John’s previous work experience includes positions held as CEO at Sana Security, CrossLoop and Ampilion,  CTO at Sagent Technology, engineer at Nasa and Lawrence Livermore National Laboratory, and VP of Engineering at Reportsmith.


William Gonzales, Vice President, Sales (B2B)

As a highly accomplished sales leader, William has in-depth experience in building and leading teams within the CPG and technology sectors.  William holds a Bachelor’s of Science degree from the University of Southern California in Marketing, Sales Force Management.  William’s previous professional experience includes VP of Sales at Quotient Technology and Shopkick, as well as sales positions held at Proctor & Gamble, PepsiCo and Valassis.


William “Bryan” Fuhr, Vice President, Bus Development (Healthcare)

As a veteran of Business Development and Sales, Bryan has led teams toward successful outcomes within the healthcare information technologies sector.  Bryan holds a Bachelor of Science in Electrical & Electronics Engineering from the University of Minnesota as well as an MBA from the University of St. Thomas-Opus College of Business.  Bryan’s previous professional experience includes VP Business Development and Sales positions at AlumiPlate, Healthsense and Best Buy Health.  


Nita Nehru, Vice President, Communications

Nita leads all internal and external communications at Kinsa, and started the company’s flagship school health program, FLUency, now in 5000 elementary schools nationwide. Nita’s career has included leadership roles in health and education startups and nonprofits, including consulting for the United Nations Development Program. She holds a Masters degree from Columbia University’s School of International and Public Affairs and an undergraduate degree from Claremont McKenna College.

John Schulte, Vice President, Software Engineering

John is an experienced engineering leader and backend engineer with an entrepreneurial-like focus on outlier detection, machine learning, team facilitation/management, and API development.  John holds a BA in Economics from the University of California, Berkeley.  John’s previous professional experience includes positions held as CTO at DabNab and Remedy Labs, and cofounder of Fanbase Media.


Nina Siglin, Vice President, Human Resources

Nina is a comprehensive Human Relations executive with extensive multi-vertical experience and specialized focus in strategic people initiatives within high growth environments.  Nina holds a BA in Psychology and a BA in Legal Studies from the University of California, Santa Cruz. She earned her Master’s of Art degree from Argosy University in Forensic Psychology.  Nina’s previous professional experience includes VP of HR at Snap Kitchen, as well as Director of HR at Krogman Construction, Beautifull, and MOC Products.

Selected Advisors & Board Members

Nirav Shah, MD, MPH, Board Member

Dr. Shah is Senior Scholar at Stanford University’s School of Medicine and Chief Medical Officer of Sharecare. He is a distinguished healthcare leader with experience as an independent director, operator, scientist, innovator, and regulator. His expertise spans public and private health insurance markets, healthcare innovation and entrepreneurship, pharmaceuticals and medical devices, clinical operations across the continuum of care, and regulatory oversight of healthcare and public health.  Previously, he served as senior vice president and Chief Operating Officer for clinical operations for Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.  Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He completed his residency in Internal Medicine at Yale, followed by fellowship in the Robert Wood Johnson Clinical Scholars Program at UCLA.

Richard Lim, MBBS, MBA, Board Member

As co-founder and Managing Director of GSR Ventures, Richard Lim focuses on investments in early-stage companies that apply artificial intelligence to healthcare and enterprise sectors. Prior to GSR Ventures, Richard was a serial entrepreneur. He was also an executive at Lotus Development Corp. and the National University Hospital of Singapore.  Richard earned an MBBS degree (MD equivalent) from the National University of Singapore and an MBA from Stanford University where he was an Arjay Miller Scholar. 

Beth Seidenberg, MD, Board Member

A longtime life sciences investor, founding managing director of Westlake Village BioPartners, and a partner at Kleiner Perkins, Dr. Seidenberg has incubated and invested in more than 20 healthcare companies during her career. Prior to life science investing, Dr. Seidenberg’s career focused on developing new treatments for AIDS, arthritis, asthma, cancer and psoriasis, cardiovascular, metabolic, neurological and renal disorders for over 20 years. During that time, she introduced 10 innovative products to the market.

Dr. Seidenberg holds a Bachelor of Science degree in biology and anthropology from Barnard College and attended medical school at the University of Miami School of Medicine. She completed her medical residency at Johns Hopkins University and George Washington University, and Fellowship at the National Institutes of Health.

James Lawler, MD, MPH, Advisor

Dr. James Lawler is Executive Director for International Programs and Innovation for the Global Center for Health Security at the University of Nebraska Medical Center. He is an Associate Professor of Medicine in Infectious Disease and Deputy Medical Director for the Nebraska Biocontainment Unit.  Dr. Lawler’s work has spanned a broad array of research, policy, and field activities related to emerging and high-consequence infectious diseases, medical and public health preparedness, pandemic and outbreak response, and global health. Dr. Lawler served in national policy positions in both the White House Homeland Security Council Biodefense Office and the National Security Council Resilience Directorate spanning two administrations. In 2012 Dr. Lawler founded the Austere environment Consortium for Enhanced Sepsis Outcomes (ACESO), an international research collaboration focused on improving sepsis survival in resource-limited settings and conducting high-impact research in 6 countries across 4 continents.

Carter Mecher, MD, Advisor

Dr. Carter Mecher has held a number of positions in medical preparedness and public health. Most recently, he was Senior Medical Advisor for the Office of Public Health in the U.S. Department of Veterans Affairs, and from 2005-2011, Director of Medical Preparedness Policy at the White House Homeland Security Council and National Security Staff. He was a principal author of the National Strategy for Pandemic Influenza Implementation Plan, and helped set policy and devise strategies to mitigate the consequences of a pandemic and promote pandemic preparedness. Prior to serving in the White House, Dr. Mecher was the Chief Medical Officer for the Southeast VA Network in Atlanta from 1996 to 2005. Dr. Mecher completed a residency in internal medicine and a fellowship in critical care medicine at Los Angeles County/USC Medical Center.


Vik Bakhru, MD, MBA, Advisor

Physician, senior healthcare executive, and serial entrepreneur. Vik Bakhru is currently serving as Chief Medical Officer & Head of Mosaic (Partnerships/Strategy) for Circulo Health. Extensive digital health, health services, insurance, technology, telemedicine, and venture-funded business experience. Vik has deep domain expertise in building and contracting with hospital networks as well as recruiting, training and managing physicians for clinical and non-clinical roles in over 14 countries globally. Recognitions include the American Medical Association Foundation Excellence in Leadership Award, The George Washington University Award, the Kaiser Family Foundation Grant, the Becker’s Hospital Review: Rising Stars in Healthcare Award, and the Wharton Forty Under Forty for 2017. Vik holds a BA in Economics and a BS in Biology from The Columbian College of Arts & Sciences of The George Washington University, an MD from The George Washington University School of Medicine & Health Sciences, and an MB. from The Wharton School of the University of Pennsylvania.


Jacob Reider, MD, CEO, Advisor

Dr. Reider currently serves as the CEO of Huddle Health.  He has worked for decades to improve the health of our communities through the innovative use of technology, and the promotion of benevolence in business.  He previously served as CEO of Alliance For Better Health, a New York DSRIP care transformation initiative, Chief Health Officer of Physera, and co-founder of RS Partners, a health IT consulting and investing firm. Additionally, he worked in the federal government as the Deputy National Coordinator for Health Information Technology at the US Department of Health and Human Services.  He has more than 20 years of experience in health information technology with a special interest in user experience, clinical decision support and information portability. He served as the CMIO of Allscripts, one of the nation’s largest health IT developers, and was Associate Dean for Biomedical Informatics at Albany Medical College where he continues to teach on an adjunct basis. He co-founded four successful health IT start-up companies, and has held Directorships on boards of both nonprofits and private companies. He has also held leadership roles in the American Medical Informatics Association and the New York State Academy of Family Physicians. He holds a BA in Cognitive Science from Hampshire College and an MD from Albany Medical College.


Ken Staley, MD, MPA, Advisor

Currently serving as Vice President Growth and Strategy at Optum, as well as Senior Associate Global Health Policy Center at the Center for Strategic and International Studies.  Dr. Staley serves on the boards of the RBM Partnership to End Malaria as well as Harvard University's Defeating Malaria Initiative. Previously, he was the leader of the U.S. President’s Malaria Initiative (PMI), the largest bilateral effort in history to eradicate malaria. At PMI, he created advanced data and analytics capabilities that integrate climate, epidemiological, financial, and operations data. During the Covid-19 pandemic he was the executive director for USAID’s COVID-19 Task Force, where he was responsible for safety, security, continuity of operations, and response and led USAID’s planning for distribution of the Covid-19 vaccine. Prior to his appointment as malaria coordinator, Dr. Staley was a consultant at McKinsey & Company, where he advised private sector clients and assisted public health responses to Ebola and MERS. He began his career in the private sector at Medtronic, where he led new ventures in China and India focused on expanding patient access through business model innovation. Before entering the private sector, Dr. Staley was the deputy assistant secretary of state for counterproliferation (acting), and director for biodefense policy at the White House Homeland Security Council, where he helped to design and then lead implementation of the National Strategy for Pandemic Influenza. He received his MD from the University of Iowa Carver College of Medicine, MPA from the Harvard Kennedy School, and is an honors graduate of Washington University in Saint Louis.


Sunny Kumar, MD, MBA, Board Observer

Sunny Kumar is a Partner at GSR Ventures, where he focuses on investments in early-stage companies applying artificial intelligence and machine learning technologies to the healthcare sector. He is a physician as well as a published medical researcher with a focus on informatics and artificial intelligence.

Sunny is a serial entrepreneur and most recently founded a company to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology. Sunny received a BS in Molecular Biology from Yale University, an MD from Stanford University School of Medicine, and an MBA from Stanford University Graduate School of Business.